Retirees interest group supports California’s pay-for-delay ban
10-03-2020
Par avoids pay-for-delay suit after court accepts payment was ‘fair’
10-03-2020
GSK’s Seroxat pay-for-delay deals may restrict competition: AG
23-01-2020
nitpicker / Shutterstock.com
The Court of Justice of the European Union (CJEU) has ruled that pharmaceutical pay-for-delay agreements may violate the Treaty on the Functioning of the European Union (TFEU), in comments passed down on January 30, 2020.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
The Court of Justice of the European Union, CJEU, clarification, UK, pay-for-delay, generics, TFEU, Competition Appeal Tribunal, pharmaceuticals, patents
